Scientists Fine-Tune lifesaving botulism treatment for kids
NCT ID NCT02051062
Summary
This study aims to verify that the current recommended dose of a botulism antitoxin (BAT) is correct for children. It involves up to 10 children under 12 years old who are receiving the antitoxin for a confirmed or suspected botulism exposure. Researchers will take a few small blood samples to measure how the medicine moves through a child's body and will monitor for any safety issues for 30 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BOTULISM are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.